Reports for STERIMAX INC
Company Name
STERIMAX INC
Totals |
||
Shortage reports |
150 |
|
| Actual shortage: | 21 (14%) | |
| Anticipated shortage: | 1 (1%) | |
| Avoided shortage: | 3 (2%) | |
| Resolved: | 125 (83%) | |
Discontinuation Reports |
5 |
|
| To be discontinued: | 1 (20%) | |
| Discontinued: | 4 (80%) | |
| Reversed: | 0 (0%) | |
Late reports |
28 (18%) |
|
Overdue reports |
9 (39%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| FENTANYL INJECTION BP | 250MCG | SOLUTION | Resolved | 2024-03-07 | 2024-06-14 | 221598 |
| FENTANYL INJECTION BP | 250MCG | SOLUTION | Resolved | 2024-11-14 | 2025-02-15 | 242920 |
| FENTANYL INJECTION BP | 1000MCG | SOLUTION | Resolved | 2024-08-29 | 2024-09-07 | 236211 |
| FENTANYL INJECTION BP | 2500MCG | SOLUTION | Resolved | 2025-02-03 | 2025-02-08 | 249443 |
| FOMEPIZOLE FOR INJECTION | 1G | SOLUTION | Resolved | 2019-08-16 | 2019-08-24 | 91678 |
| FOMEPIZOLE FOR INJECTION | 1G | SOLUTION | Resolved | 2024-11-25 | 2024-12-20 | 243759 |
| FUROSEMIDE INJECTION USP | 10MG | SOLUTION | Resolved | 2017-10-18 | 2018-03-03 | 26269 |
| FUROSEMIDE INJECTION USP | 10MG | SOLUTION | Resolved | 2022-06-27 | 2022-08-05 | 163468 |
| FUROSEMIDE INJECTION USP | 10MG | SOLUTION | Resolved | 2024-10-01 | 2024-10-29 | 239042 |
| GLYCOPYRROLATE INJECTION USP | 0.2MG | SOLUTION | Resolved | 2022-09-14 | 2023-01-19 | 169242 |
| GLYCOPYRROLATE INJECTION USP | 0.2MG | SOLUTION | Resolved | 2023-08-01 | 2023-09-30 | 200632 |
| GLYCOPYRROLATE INJECTION USP | 0.2MG | SOLUTION | Actual shortage | 2024-11-28 | 2025-04-10 | 244055 |
| GLYCOPYRROLATE INJECTION USP | 0.4MG | SOLUTION | Resolved | 2023-01-19 | 2023-04-17 | 181847 |
| GLYCOPYRROLATE INJECTION USP | 0.4MG | SOLUTION | Actual shortage | 2024-12-12 | 2025-04-10 | 245519 |
| GLYCOPYRROLATE INJECTION USP | 4MG | SOLUTION | Resolved | 2022-12-06 | 2023-02-02 | 177192 |
| GLYCOPYRROLATE INJECTION USP | 4MG | SOLUTION | Actual shortage | 2024-08-08 | 2025-04-10 | 234808 |
| HYDROMORPHONE HYDROCHLORIDE INJECTION | 2MG | SOLUTION | Resolved | 2022-02-17 | 2022-03-04 | 155221 |
| KETAMINE INJECTION, BP | 50MG | SOLUTION | Resolved | 2024-08-08 | 2024-08-23 | 234822 |
| KETOTIFEN OPHTHALMIC SOLUTION | 0.25MG | SOLUTION | Resolved | 2017-06-15 | 2017-08-15 | 12797 |
| KETOTIFEN OPHTHALMIC SOLUTION | 0.25MG | SOLUTION | Resolved | 2019-03-15 | 2019-07-02 | 78723 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| BUPIVACAINE HYDROCHLORIDE INJECTION, USP | 7.5MG | SOLUTION | Discontinued | 2024-01-15 | 2024-06-01 | 216017 |
| MYCOPHENOLATE MOFETIL FOR INJECTION USP | 500MG | POWDER FOR SOLUTION | Discontinued | 2024-01-22 | 2024-08-07 | 216963 |
| PHENYLEPHRINE HYDROCHLORIDE INJECTION USP | 10MG | SOLUTION | Discontinued | 2024-03-22 | 2024-08-08 | 223140 |
| PHENYLEPHRINE HYDROCHLORIDE INJECTION USP | 10MG | SOLUTION | Discontinued | 2024-03-22 | 2024-08-07 | 223145 |
| STREPTOMYCIN FOR INJECTION USP | 1G | POWDER FOR SOLUTION | To be discontinued | 2025-04-10 | 2025-04-10 | 254712 |
Showing 1 to 5 of 5